Pelzer, F., Ertekin, E., Oleshko, O., Klingberg, A., Knoebl, P., Pfrepper, C., Greil, R., Oldenburg, J., Sachs, U., Miesbach, W., Trautmann-Grill, K., Holstein, K., Eichler, H., Moehnle, P., Hart, C., Klamroth, R., Tiede, A., Werwitzke, S. (2025). Using FXIa-triggered thrombin generation to assess the risk of breakthrough bleeding in patients receiving emicizumab for acquired Hemophilia A. Blood. https://doi.org/10.1182/blood-2025-310